Hosted on MSN23d
GeneDx targeted in short report by Grizzly ResearchInvesting.com -- Grizzly Research has shorted GeneDx, a genetic testing company, accusing them of widespread fraud. GeneDx specializes in advanced genomic testing, with a focus on rare and ultra ...
NEW YORK, NY / / February 25, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of ...
Update 3pm: Adds analyst comment. GeneDX (NASDAQ:WGS) fell 4% after a short report from Grizzly Research on the genetic testing company. Grizzly Research disclosed that it's short shares of GeneDX ...
Grizzly Research ("Grizzly") published a report on February 5, 2025, entitled "Insiders Attest That GeneDx (Nasdaq: WGS) Is Actively Committing Widespread Fraud". The Grizzly report asserted ...
Grizzly Research ("Grizzly") published a report on February 5, 2025, entitled "Insiders Attest That GeneDx (Nasdaq: WGS) Is Actively Committing Widespread Fraud". The Grizzly report asserted ...
Grizzly Research ("Grizzly") published a report entitled "Insiders Attest That GeneDx (Nasdaq: WGS ) Is Actively Committing Widespread Fraud". The Grizzly report asserted, among other things ...
Grizzly Research ("Grizzly") published a report on February 5, 2025, entitled "Insiders Attest That GeneDx (Nasdaq: WGS) Is Actively Committing Widespread Fraud". The Grizzly report asserted ...
Grizzly Research ("Grizzly") published a report on February 5, 2025, entitled "Insiders Attest That GeneDx (Nasdaq: WGS) Is Actively Committing Widespread Fraud". The Grizzly report asserted ...
Grizzly Research ("Grizzly") published a report on February 5, 2025, entitled "Insiders Attest That GeneDx (Nasdaq: WGS) Is Actively Committing Widespread Fraud". The Grizzly report asserted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback